Thomas Sejersen holds positions as Professor in Neuropediatrics at the Department of Women’s and Children’s Health of Karolinska Institute and consultant paediatrician at the Astrid Lindgrens Barnsjukhus (Stockholm, Sweden).
He is a paediatric neurologist with special clinical and research interest in neuromuscular disorders. Thomas Sejersen conducts translational and clinical research into congenital myopathies, primarily desmin-related myopathies, spinal muscular atrophy and Duchenne muscular dystrophy, including clinical trials. His major role in TREAT-NMD is the development of standards of care for several paediatric neuromuscular disorders. He is also engaged in validation processes in the NMD-CHIP project, aiming to improve high throughput genetic diagnosis of neuromuscular disorders. Thomas is member of the board of European Paediatric Neurology Society.